An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model

Molecular Vision

Volumn 19, Issue , 2013, Pages 2135-2150

  Uchiyama, Masaaki ^a   Shimizu, Akira ^a   Masuda, Yukinari ^a   Nagasaka, Shinya ^a   Fukuda, Yuh ^a   Takahashi, Hiroshi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; EYE DROPS; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAUSTIC BURN; CELL INFILTRATION; CELL METABOLISM; COLLAGEN METABOLISM; CONTROLLED STUDY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; DRUG EFFICACY; HISTOLOGY; IMMUNOCHEMISTRY; INFLAMMATORY CELL; KERATITIS; MACROPHAGE; MALE; MYOFIBROBLAST; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WOUND HEALING;

ALKALIES; ANIMALS; BURNS, CHEMICAL; CHEMOKINES; COLLAGEN TYPE III; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL OPACITY; DISEASE MODELS, ANIMAL; EYE BURNS; FIBROSIS; INFLAMMATION; MACROPHAGES; MALE; NEUTROPHIL INFILTRATION; OPHTHALMIC SOLUTIONS; PPAR GAMMA; RATS; RATS, WISTAR; RNA, MESSENGER; THIAZOLIDINEDIONES; WOUND HEALING;

EID: 84887181014     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 2005; 65:772-781. [PMID: 15721857].
2. Evans RM. The steroid and thyroid hormone receptor super-family. Science 1988; 240:889-895. [PMID: 3283939].
3. Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxi-some proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2011; 2:236-240. [PMID: 22247890].
4. Széles L, Töröcsik D, Nagy L. PPARgamma in immunity and inflammation: cell types and diseases. Biochim Biophys Acta 2007; 1771:1014-30. [PMID: 17418635].
5. Schmidt MV, Brüne B, von Knethen A. The nuclear hormone receptor PPARγ as a therapeutic target in major diseases. ScientificWorld Journal 2010; 10:2181-2197. [PMID: 210 57731].
6. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391:79-82. [PMID: 9422508].
7. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391:82-86. [PMID: 9422509].
8. von Knethen A, Brüne B. PPARgamma-an important regu-lator of monocyte/macrophage function. Arch Immunol Ther Exp (Warsz) 2003; 51:219-226. [PMID: 12956430].
9. Aljada A, O'Connor L, Fu Y Y, Mousa SA. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. Angiogenesis 2008; 11:361-367. [PMID: 18810 6 47].
10. Hatanaka H, Koizumi N, Okumura N, Kay EP, Mizu-hara E, Hamuro J, Kinoshita S. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists. Invest Ophthalmol Vis Sci 2012; 53:6955-6963. [PMID: 22956604].
11. Taguchi K, Okada A, Yasui T, Kobayashi T, Ando R, Tozawa K, Kohri K. Pioglitazone, a peroxisome proliferator activated receptor γ agonist, decreases renal crystal deposition, oxida-tive stress and inflammation in hyperoxaluric rats. J Urol 2012; 188:1002-1011. [PMID: 2 2819112].
12. Yu Y, Zhang ZH, Wei SG, Weiss RM, Felder RB. Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. Hypertension 2012; 59:477-484. [PMID: 22 0 83161].
13. Reddy AT, Lakshmi SP, Kleinhenz JM, Sutliff RL, Hart CM, Reddy RC. Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury. J Immunol 2012; 189:5411-5420. [PMID: 23105142].
14. Saika S, Yamanaka O, Okada Y, Miyamoto T, Kitano A, Flanders KC, Ohnishi Y, Nakajima Y, Kao WW, Ikeda K. Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice. Am J Physiol Cell Physiol 2007; 293:C75-C86. [PMID: 1762 50 41].
15. Sarayba MA, Li L, Tungsiripat T, Liu NH, Sweet PM, Patel AJ, Osann KE, Chittiboyina A, Benson SC, Pershadsingh HA, Chuck RS. Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Exp Eye Res 2005; 80:435-442. [PMID: 15721625].
16. Gao D, Ning N, Hao G, Niu X. Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats. PPAR Res 2012; 2012:856426-[PMID: 22550475].
17. Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 2012; 23:351-363. [PMID: 22704720].
18. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001; 159:599-608. [PMID: 114 85918].
19. Fujita E, Shimizu A, Masuda Y, Kuwahara N, Arai T, Naga-saka S, Aki K, Mii A, Natori Y, Iino Y, Katayama Y, Fukuda Y. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol 2010; 177:1143-1154. [PMID: 20696778].
20. Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 2002; 13:1795-1805. [PMID: 12089375].
21. Shimizu A, Masuda Y, Mori T, Kitamura H, Ishizaki M, Sugi-saki Y, Fukuda Y. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 2004; 15:2655-2665. [PMID: 15466270].
22. Wakamatsu K, Ghazizadeh M, Ishizaki M, Fukuda Y, Yamanaka N. Optimizing collagen antigen unmasking in paraffin-embedded tissues. Histochem J 1997; 29:65-72. [PMID: 9088946].
23. Tanabe M, Shimizu A, Masuda Y, Kataoka M, Ishikawa A, Wakamatsu K, Mii A, Fujita E, Higo S, Kaneko T, Kawachi H, Fukuda Y. Development of lymphatic vasculature and morphological characterization in rat kidney. Clin Exp Nephrol 2012; 16:833-842. [PMID: 22581062].
24. Pfister RR, Pfister DR. Alkali injuries of the eye. In: K rachmer JH, mannis MJ, Holland EJ, editors. CORNEA. 2nd Edition ed 2005. p. 1285-1293.
25. Paterson CA, Williams RN, Parker AV. Characteristics of poly-morphonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. Exp Eye Res 1984; 39:701-708. [PMID: 6097468].
26. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997; 41: 275-313. [PMID: 910 4767].
27. Pfister RR, Haddox JL, Lank KM. Citrate or ascorbate/citrate treatment of established corneal ulcers in the alkali-injured rabbit eye. Invest Ophthalmol Vis Sci 1988; 29:1110-1115. [PMID: 3 4174 03].
28. Maurice DM. The structure and transparency of the cornea. J Physiol 1957; 136:263-286. [PMID: 13429485].
29. Saika S, Ooshima A, Shima K, Tanaka S, Ohnishi Y. Collagen types in healing alkali-burned corneal stroma in rabbits. Jpn J Ophthalmol 1996; 40:303-309. [PMID: 8988 419].
30. Kuriyan AE, Lehmann GM, Kulkarni AA, Woeller CF, Feldon SE, Hindman HB, Sime PJ, Huxlin KR, Phipps RP. Electro-philic PPARγ ligands inhibit corneal fibroblast to myofibro-blast differentiation in vitro: a potentially novel therapy for corneal scarring. Exp Eye Res 2012; 94:136-145. [PMID: 22178 289].
31. Pan H, Chen J, Xu J, Chen M, Ma R. Antifibrotic effect by activation of peroxisome proliferator-activated receptor-gamma in corneal fibroblasts. Mol Vis 2009; 15:2279-2286. [PMID: 19936025].
32. Pan HW, Xu JT, Chen JS. Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production. Mol Biol Rep 2011; 38:4501-4508. [PMID: 2112 79 91].
33. Lee HM, Kang HJ, Park HH, Hong SC, Kim JK, Cho JH. Effect of peroxisome proliferator-activated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Ann Otol Rhinol Laryngol 2009; 118:721-727. [PMID: 19894400].
34. Gordon S, Taylor PR. Monocyte and macrophage heteroge-neity. Nat Rev Immunol 2005; 5:953-964. [PMID: 16322748].
35. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118:3522-30. [PMID: 18982158].
36. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73:209-212. [PMID: 12554797].
37. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6:137-143. [PMID: 176 81149].
38. Charo IF. Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab 2007; 6:96-98. [PMID: 176 8114 4].
39. Sotozono C, He J, Matsumoto Y, Kita M, Imanishi J, Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997; 16:670-676. [PMID: 9222084].
40. Saika S. TGFbeta pathobiology in the eye. Lab Invest 2006; 8 6:106-115. [PMID: 16 3 410 2 0].
41. Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Nakajima Y, Kao WW, Flanders KC, Roberts AB. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol 2005; 166:1405-1418. [PMID: 158556 41].